Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to email@example.com so that we can defer those challenges. Your health and safety are paramount to us.
Posted 04 June 2012 | By Ansis Helmanis,
China's State Food and Drug Administration (SFDA) has issued a draft "blacklist" proposal that would be used for listing serious violators of laws and regulations. The 28 May list was sent to provinces and municipalities, and contains examples of the kind of violations that would support blacklisting a company.
Examples provided include sales of counterfeit drugs, production and sale of inferior drugs, failure to obtain medical device registration certificate and device production which does not meet national standards.
The blacklist will also contain the personnel responsible for the regulatory violations rather than just the company to prevent personnel from establishing other companies or moving within the industry.
SFDA - Proposed Blacklist
More Breaking News from RegLink
Tags: Blacklist, SFDA, pharmaceutical, drug